Robciuc et al. [32] found that Vegfb transduction reverted glucose intolerance in the preclinical mouse model of metabolic syndrome, stimulated fat burning, augmented basal oxygen consumption and metabolic rate, acting protectively against diet-induced obesity and metabolic complications. Here, VEGFB is linked to obesity due to melanocortin 4 receptor deficiency.